1832 Asset Management L.P. Insulet Corp Transaction History

1832 Asset Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $6.37 Million - $9.4 Million	30,000 New	30,000 $8.83 Million
Q2 2021 Aug 16, 2021	SELL	$225.52 - $304.06 $113 Million - $153 Million	-502,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $35.3 Million - $43.5 Million	163,600 Added 48.23%	502,800 $130 Million
Q3 2020 Nov 16, 2020	BUY	$192.55 - $236.59 $65.3 Million - $80.3 Million	339,200 New	339,200 $78.3 Million
Q1 2020 May 14, 2020	SELL	$130.01 - $216.44 $82.1 Million - $137 Million	-631,200 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$144.81 - $186.0 $8.79 Million - $11.3 Million	-60,700 Reduced 8.77%	631,200 $106 Million
Q3 2019 Nov 14, 2019	SELL	$117.35 - $167.95 $46,940 - $67,180	-400 Reduced 0.06%	691,900 $111 Million
Q2 2019 Aug 14, 2019	BUY	$82.13 - $120.73 $56.9 Million - $83.6 Million	692,300 New	692,300 $79 Million

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.